최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기大韓韓方小兒科學會誌 = The journal of pediatrics of Korean medicine, v.32 no.4, 2018년, pp.1 - 12
서일복 (세명대학교 한의과대학 해부학교실) , 안상현 (세명대학교 한의과대학 해부학교실) , 김기봉 (부산대학교한방병원 한방소아과)
Objectives Bangpungtongsungsan is an herbal medicine that treats obesity and dampness-phlegm. The aim of this study was to investigate the efficacy of Bangpungtongsungsan on insulin resistance induced by non-alcoholic fatty liver disease. Methods Male 6-week-old C57BL/6 male mice were divided into f...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
선진국에서의 NAFLD의 유병률은? | NAFLD의 유병률은 세계 여러 국가에서 증가하고 있으며 국내에서도 최근 증가하고 있다. 국가마다 차이가 있지만 선진국에서는 전체 인구의 약 20~30%로 보고되고 있으며, 이러한 유병률의 증가는 성인과 소아 비만의 증가와 관련성이 높다24). 최근 NAFLD는 인슐린저항성을 근간으로 한 비만, 고혈압, 제2형 당뇨병, 지질대상이상과 같이 간에 나타나는 대사증후군의한 상태로 간주되고 있다. | |
NAFLD의 유병률이 2004년 11.5%에서 2010년 23.6%로 6년 사이 2배로 급격히 증가한 원인은? | 비알콜성 지방간질환 (non-alcoholic fatty liver disease, NAFLD)은 유의한 분량의 알코올 섭취가 없음에도 알코올 간염과 비슷한 조직소견을 보이는 질환으로,간세포에 지방의 과도한 축적만 있는 단순 지방증(simple steatosis), 간세포 괴사와 염증과 섬유화를 동반하는 비알콜성 지방간염 (non-alcoholic steatohepatitis,NASH) 및 더 진행된 형태인 간경변증 (liver cirrhosis)을 포함하는 일련의 질환군을 의미한다1). 서구화된 식생활로 인한 국내 비만 증가율이 높아짐에 따라NAFLD의 유병률이 2004년 11.5%에서 2010년 23. | |
비알콜성 지방간질환이란? | 비알콜성 지방간질환 (non-alcoholic fatty liver disease, NAFLD)은 유의한 분량의 알코올 섭취가 없음에도 알코올 간염과 비슷한 조직소견을 보이는 질환으로,간세포에 지방의 과도한 축적만 있는 단순 지방증(simple steatosis), 간세포 괴사와 염증과 섬유화를 동반하는 비알콜성 지방간염 (non-alcoholic steatohepatitis,NASH) 및 더 진행된 형태인 간경변증 (liver cirrhosis)을 포함하는 일련의 질환군을 의미한다1). 서구화된 식생활로 인한 국내 비만 증가율이 높아짐에 따라NAFLD의 유병률이 2004년 11. |
Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40 Suppl 1:S5-10.
Korea Food & Drug Administration. The press release [Internet]. [Retrieved Nov. 14, 2013]. Available from: http://www.mfds.go.kr/index.do?mid675&seq19618&cmdv
Oh K, Jang MJ, Lee NY, Moon JS, Lee CG, Yoo MH, Kim YT. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatr. 2008;51(9):950-5.
Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis. 2010;28(1):155-61.
Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008;28(1):13-24.
Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11(1):74-80.
Ahn YJ, Yoon KH, Jo JH, Jang DH, Jung YS, Kim JH, Kim BC, Seok HJ, Yoo JS, Ku JR, Yoon M, Shin SS. Gangjihwan improves nonalcoholic fatty liver disease in high fat diet-fed C57BL/6N mice. Kor J Herbology. 2014;29(2):47-54.
Lee BW. Management of patients with nonalcoholic fatty liver disease with lifestyle modification. Korean Diabetes. 2018;19:82-7.
Cone CJ, Bachyrycz AM, Murata GH. Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. Ann Pharmacother. 2010;44(10):1655-9.
Peterfy M, Phan J, Xu P, Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet. 2001; 27(1):121-4.
Xu J, Lee WN, Phan J, Saad MF, Reue K, Kurland IJ. Lipin deficiency impairs diurnal metabolic fuel switching. Diabetes. 2006;55(12):3429-38.
Yao-Borengasser A, Rasouli N, Varma V, Miles LM, Phanavanh B, Starks TN, Phan J, Spencer HJ, McGehee RE, Reue K, Kern PA. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes. 2006;55(10):2811-8.
Hong JY. Effects of Bangpungtongseungsan and Monacolin K. on body weight, food consumption, serum and expression of ${\beta}3AR$ in high fat mice. Wonkwang University Doctor's Thesis. 2009.
Choi EM, Ryu EK. Effects of Fangfengtongsheng-san on obese patients. J Soc Korean Med Obes Res. 2001; 1(1):57-62.
Ahn JM, Kim SS, Shin HD. Effects of Bangpoongtongsungsan on the weight and lipid metabolism of induced obesity rats. J Kyung Hee Univ Med Cent. 1993;9(1):69-82.
Hwang SJ, Song TW, Oh MS. The inhibitory effects of Bangpungtongseoung-san on the obese gene and obese inhibitory about obese-mouse induced by high fat diet. J Korean Orient Med. 2006;27(1):11-22.
Shin BC, Song YS. Effects of Bangpungtongseoungsan on rats with adipocyte induced by gold thioglucose. J Korean Med Rehabil. 1997;7(1):101-19.
Akbar DH, Kawther AH. Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. Diabetes Care. 2003;26(12):3351-2.
Jang YS, Seo JY, kwun MJ, Kwon JN, Lee I, Hong JW, Kim SY, Choi JY, Park SH, Joo M, Han CW. Effect of Phaseolus angularis seed on experimental cellular model of nonalcoholic fatty liver disease. Korean J Orient Physiol Pathol. 2013;27(6):802-8.
Kim SY, Kwon JN, Lee I, Hong JW, Choi JY, Park SH, Kwon MJ, Joo M, Han CW. Research on anti-lipogenic effect and underlying mechanism of Laminaria japonica on experimental cellular model of non-alcoholic fatty liver disease. J Int Korean Med. 2014;35(2):175-83.
Han CW, Lee JH. Effects of KHchunggan-tang on the nonalcoholic fatty liver disease in palmitate-induced cellular model. J Korean Orient Med. 2011;32(1):109-20.
Kim K, Ko H, Shin S. Diagnostic process analysis of prescribing Injinho-tang in non alcohoic fatty liver disease using by AHP. J Soc Korean Med Diagn. 2015; 19(3):159-71.
Jung YS, Kim JH, Kim BC, Seok HJ, Yoo JS, Ku JR, Yoon KH, Jo JH, Jang DH, Yun HY, Yoon M, Shin SS. Comparison of Gangjihwan-1,2,3,4 and combination of Gangjihwan-1 and Gamisochehwan in the improvement effects of nonalcoholic fatty liver disease in a high fat diet-fed obese mouse model. Kor J Herbology. 2014;29(6):149-56.
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-95.
Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129(1):375-8.
Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44(4):865-73.
Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology. 2004;40(4):820-6.
Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113-21.
Son CK. The research of immunological function in liver. J Korean Orient Med. 2001;22(1):3-9.
Lee SM, Kim BW, Kwon KR, Rhim TJ, Kim DH. The effect of Bangpungtongsung-san extracts on adipocyte metabolism. J Pharmacopuncture. 2008;11(1):163-76.
Jeong SH, Lee KT, Ann HS, Lee JY, Choi JW, Kim DG. Hypolipidemic and antioxidative effects of Bangpoongtongsungsankamibang on diet-induced obesity rats. 2006;37(3):190-5.
Lee JC. Effects of Gamibangpungtongseungsan on lipid composition and antioxidant in rat fed high fat. Kor J Herbology. 2005;20(2):69-75.
Lee NH, Shin GJ, Cho KH, Kim S, Bae HS, Lee KS. Effect of Bangpoorgtonsungsan on the hypertention and hyperlipidemia. J Kyung Hee Univ Med Cent. 1991; 22(1):101-9.
Yun KY. Donguiimsangbangjehag. Seoul: Myungbo Publishing Co. 1992:52-4.
Hwang DY. Bangyakhappyeon. Seoul: Namsandang. 1987:122.
Park MJ, Kim DI, Lim SK, Choi JH, Kim JC, Yoon KC, Lee JB, Lee JH, Han HJ, Choi IP, Kim HC, Park SH. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC- $1{\alpha}$ regulation in vitro and in vivo. J Hepatol. 2014;61(5): 1151-7.
Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45(6):1366-74.
Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, Gores GJ. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology. 2004;40(1):185-94.
Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis. 2008;28(4):370-9.
Kim TH. Obesity and fatty liver disease. Korean J Med. 2005;68(4):347-50.
Baeuerle PA, Baltimore D. NF- ${\kappa}B$ : ten years after. Cell. 1996;87(1):13-20.
Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 2003;17(14):2115-7.
Cha HY, Ahn SH, Cheon JH, Park IS, Kim JT, Kim KB. Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC/Nga mice under high-fat diet conditions. Evid Based Complement Alternat Med. 2016;2016:1-13.
Lipscombe LL, Gomes T, Levesque LE, Hux JE, Juurlink DN, Alter DA. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA. 2007;298(22):2634-43.
Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA. 2007;298(10):1180-8.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.